Two Drugmakers Dominate Obesity Boom, Tiny Fund Holds Both
Two drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Discover ways to give back while enjoying your community. This guide pairs volunteering opportunities with free events to help you do more for less.
28,655 articlesTwo drugmakers lead the obesity drug surge, while a small fund owns both names at a fractional stake. This highlights...
Bitcoin climbed through the 65,000 level, signaling fresh momentum. Traders weigh whether the rally will last or fade...
Bitcoin remains trapped in a broader bearish structure, but a short-term rebound has formed from the $60,000–$62,000 ...
As 2026 opens with mixed signals, investors seek ballast. This story examines three dividend ETFs that actually shiel...
Cisco is betting on AI infrastructure and recurring revenue to escape dot-com era fears. With rising ARR, rising subs...
Archer Aviation counters Jobs, accusing Joby of government misrepresentation and hidden foreign ties. The ongoing dis...
Bitcoin rallies as investors pivot away from bullion and into digital assets. The shift coincides with renewed Israel...
SVOL harvests the volatility risk premium by shorting VIX futures, paying a high dividend, yet a volatile market test...
Strategy reported a $12.54 billion Q1 loss driven by unrealized BTC declines, even as its software business expanded ...
Micron Technology rides a rapid AI-fueled rally into May, fueling debate among investors about whether to sell or hol...
As inflation reaccelerates, a potential rate hike under a new Fed chair could complicate Trump’s midterm plans and ri...
Oil prices stayed contained as Beijing taps strategic stockpiles, a trend analysts say explains why crude hasn’t surg...